Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

EDIT Insider Trading (Editas Medicine)

Insider Ownership Percentage: 0.44%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $778,122.31

Editas Medicine Insider Trading History Chart

This chart shows the insider buying and selling history at Editas Medicine by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Editas Medicine Share Price & Price History

Current Price: $12.37
Price Change: Price Increase of +0.54 (4.56%)
As of 07/1/2022 11:03 AM ET

This chart shows the closing price history over time for EDIT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Former Lawyer Went From $50K To $5.3M Trading Options
Slaving away for 70 hrs a week as a lawyer in Chicago, I was miserable.

I ran into guys who worked the trading floor at the local exchange. I began trading the same way they did. I started out with $50K (much more than I needed, actually).

I grew my $50K into $5.3M
I'll show you how I did it here.

Editas Medicine Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2022Mark S ShearmanEVPSell5,145$10.06$51,758.7068,349View SEC Filing Icon  
6/3/2022Bruce EatonEVPSell1,123$11.54$12,959.4265,421View SEC Filing Icon  
6/3/2022Michelle RobertsonCFOSell1,527$11.54$17,621.5882,667View SEC Filing Icon  
5/9/2022Bruce EatonEVPSell297$13.11$3,893.6766,544View SEC Filing Icon  
4/1/2022Bruce EatonEVPSell1,258$19.64$24,707.1266,841View SEC Filing Icon  
3/3/2022Bruce EatonEVPSell403$17.33$6,983.99View SEC Filing Icon  
3/3/2022Michelle RobertsonCFOSell767$17.33$13,292.11View SEC Filing Icon  
2/8/2022Bruce EatonEVPSell302$17.63$5,324.26View SEC Filing Icon  
1/11/2022Michelle RobertsonCFOSell1,744$25.70$44,820.80View SEC Filing Icon  
11/12/2021Lisa Anne MichaelsEVPSell1,568$38.33$60,101.44View SEC Filing Icon  
11/9/2021Bruce EatonEVPSell287$40.61$11,655.07View SEC Filing Icon  
10/18/2021James C. MullenCEOSell13,805$38.03$525,004.15View SEC Filing Icon  
6/28/2021Michelle RobertsonCFOSell2,500$50.00$125,000.00
1/12/2021Michelle RobertsonCFOSell1,568$78.27$122,727.3618,432View SEC Filing Icon  
12/15/2020Charles AlbrightEVPSell10,000$63.22$632,200.0034,907View SEC Filing Icon  
12/9/2020Charles AlbrightEVPSell10,000$45.00$450,000.0034,907View SEC Filing Icon  
12/7/2020Charles AlbrightEVPSell20,000$40.02$800,400.0044,907View SEC Filing Icon  
10/15/2020Charles AlbrightEVPSell3,000$31.39$94,170.0025,135View SEC Filing Icon  
8/20/2020Cynthia CollinsCEOSell1,976$36.66$72,440.16
8/17/2020Charles AlbrightEVPSell10,000$35.29$352,900.0038,135View SEC Filing Icon  
7/15/2020Charles AlbrightEVPSell3,000$32.22$96,660.0028,373View SEC Filing Icon  
2/3/2020Charles AlbrightInsiderSell5,549$26.54$147,270.46View SEC Filing Icon  
8/19/2019Cynthia CollinsCEOSell5,193$25.83$134,135.19View SEC Filing Icon  
See Full Table
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

SEC Filings (Institutional Ownership Changes) for Editas Medicine (NASDAQ:EDIT)

75.48% of Editas Medicine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EDIT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Editas Medicine Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/30/2022Amalgamated Bank11,152$0.21M0.0%-7.3%0.016%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE305,029$5.80M0.0%+11.8%0.444%Search for SEC Filing on Google Icon
6/2/2022Mirae Asset Global Investments Co. Ltd.217,201$4.13M0.0%-16.8%0.316%Search for SEC Filing on Google Icon
5/17/2022Quantbot Technologies LP2,353$44K0.0%N/A0.003%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada76,852$1.46M0.0%+25.6%0.112%Search for SEC Filing on Google Icon
5/17/2022Guggenheim Capital LLC54,660$1.04M0.0%+27.8%0.080%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System87,567$1.67M0.0%-7.7%0.128%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.635,549$12.09M0.0%-35.5%0.926%Search for SEC Filing on Google Icon
5/16/2022PDT Partners LLC58,201$1.11M0.1%-45.3%0.085%Search for SEC Filing on Google Icon
5/16/2022Captrust Financial Advisors2,334$44K0.0%-71.8%0.003%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP22,871$0.44M0.0%N/A0.033%Search for SEC Filing on Google Icon
5/16/2022State Street Corp5,480,038$104.23M0.0%+67.3%7.984%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP26,548$0.51M0.0%+63.1%0.039%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.56,201$1.07M0.0%+58.4%0.082%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG241,583$4.60M0.0%+70.8%0.352%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC903,400$17.18M0.0%+296.1%1.316%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp670,018$12.74M0.0%-3.5%0.976%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.497,574$9.46M0.0%+2.6%0.725%Search for SEC Filing on Google Icon
5/13/2022Lazard Asset Management LLC124,905$2.38M0.0%+37.8%0.182%Search for SEC Filing on Google Icon
5/13/2022Penserra Capital Management LLC7,772$0.15M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.33,955$0.65M0.0%-6.6%0.049%Search for SEC Filing on Google Icon
5/13/2022Ergoteles LLC50,950$0.97M0.0%+352.0%0.074%Search for SEC Filing on Google Icon
5/13/2022Covestor Ltd1,469$28K0.0%+9,693.3%0.002%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.6,876,539$130.79M0.0%+3.0%10.018%Search for SEC Filing on Google Icon
5/13/2022Blair William & Co. IL19,353$0.37M0.0%+31.0%0.028%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP866,915$16.49M0.0%-2.4%1.263%Search for SEC Filing on Google Icon
5/12/2022Cibc World Market Inc.34,489$0.66M0.0%+252.3%0.050%Search for SEC Filing on Google Icon
5/12/2022Shelton Capital Management170,000$3.23M0.1%-5.6%0.248%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.6,275,270$119.36M0.0%+15.5%9.142%Search for SEC Filing on Google Icon
5/12/2022Metropolitan Life Insurance Co NY4,564$87K0.0%-74.8%0.007%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC37,148$0.71M0.0%+57.4%0.054%Search for SEC Filing on Google Icon
5/12/2022Bank of Montreal Can51,583$1.01M0.0%N/A0.075%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.17,812$0.34M0.0%N/A0.026%Search for SEC Filing on Google Icon
5/12/2022CQS US LLC336,842$6.41M0.4%N/A0.491%Search for SEC Filing on Google Icon
5/12/2022AlphaCrest Capital Management LLC25,153$0.48M0.0%+12.3%0.037%Search for SEC Filing on Google Icon
5/12/2022PNC Financial Services Group Inc.41,811$0.80M0.0%+88.2%0.061%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.83,170$1.58M0.0%-54.7%0.121%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.182,485$3.47M0.0%+147.8%0.266%Search for SEC Filing on Google Icon
5/12/2022Cambridge Investment Research Advisors Inc.64,560$1.23M0.0%-2.0%0.094%Search for SEC Filing on Google Icon
5/11/2022US Bancorp DE12,699$0.24M0.0%+13.6%0.019%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp288,878$5.49M0.0%+0.4%0.421%Search for SEC Filing on Google Icon
5/11/2022Raymond James Financial Services Advisors Inc.36,966$0.70M0.0%-8.6%0.054%Search for SEC Filing on Google Icon
5/11/2022Nia Impact Advisors LLC154,254$2.93M1.4%+73.6%0.225%Search for SEC Filing on Google Icon
5/11/2022Skandinaviska Enskilda Banken AB publ 46,562$0.89M0.0%-24.7%0.068%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.1,256,561$23.90M0.0%-14.2%1.831%Search for SEC Filing on Google Icon
5/11/2022WINTON GROUP Ltd17,636$0.34M0.0%+23.1%0.026%Search for SEC Filing on Google Icon
5/11/2022Jennison Associates LLC52,713$1M0.0%N/A0.077%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP12,124$0.23M0.0%+8.2%0.018%Search for SEC Filing on Google Icon
5/10/2022ProShare Advisors LLC19,913$0.38M0.0%-19.0%0.029%Search for SEC Filing on Google Icon
5/10/2022Texas Yale Capital Corp.50,000$0.95M0.1%+25.0%0.073%Search for SEC Filing on Google Icon
5/10/2022Mirae Asset Global Investments Co. Ltd.217,201$4.13M0.0%-16.8%0.317%Search for SEC Filing on Google Icon
5/9/2022Principal Financial Group Inc.12,521$0.24M0.0%-36.8%0.018%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank161,700$3.08M0.0%+7.9%0.236%Search for SEC Filing on Google Icon
5/9/2022Mitsubishi UFJ Kokusai Asset Management Co. Ltd.8,939$0.17M0.0%+12.7%0.013%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd18,708$0.36M0.0%-30.2%0.027%Search for SEC Filing on Google Icon
5/6/2022Los Angeles Capital Management LLC31,889$0.61M0.0%+97.5%0.047%Search for SEC Filing on Google Icon
5/6/2022RMB Capital Management LLC84,015$1.60M0.1%+37.0%0.123%Search for SEC Filing on Google Icon
5/6/2022Nikko Asset Management Americas Inc.1,032,113$19.63M0.1%-61.4%1.506%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund49,287$0.94M0.0%-17.4%0.072%Search for SEC Filing on Google Icon
5/5/2022HCR Wealth Advisors21,000$0.40M0.1%+6.3%0.031%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.51,620$0.99M0.0%-7.6%0.075%Search for SEC Filing on Google Icon
5/4/2022Commonwealth Equity Services LLC116,003$2.21M0.0%-4.0%0.169%Search for SEC Filing on Google Icon
5/4/2022Benjamin F. Edwards & Company Inc.6,778$0.13M0.0%+56.8%0.010%Search for SEC Filing on Google Icon
5/4/2022Envestnet Asset Management Inc.24,061$0.46M0.0%+35.6%0.035%Search for SEC Filing on Google Icon
4/29/2022SG Americas Securities LLC37,914$0.72M0.0%N/A0.055%Search for SEC Filing on Google Icon
4/28/2022DekaBank Deutsche Girozentrale22,400$0.44M0.0%+9.8%0.033%Search for SEC Filing on Google Icon
4/27/2022Dupont Capital Management Corp22,027$0.42M0.0%+263.4%0.032%Search for SEC Filing on Google Icon
4/27/2022Sumitomo Mitsui Trust Holdings Inc.1,032,113$19.63M0.0%-61.4%1.506%Search for SEC Filing on Google Icon
4/26/2022Exchange Traded Concepts LLC69,276$1.32M0.0%+34.3%0.101%Search for SEC Filing on Google Icon
4/25/2022McGuire Investment Group LLC18,748$0.36M0.1%+5.4%0.027%Search for SEC Filing on Google Icon
4/25/2022Assenagon Asset Management S.A.233,487$4.44M0.0%N/A0.341%Search for SEC Filing on Google Icon
4/21/2022Zurcher Kantonalbank Zurich Cantonalbank 19,577$0.37M0.0%+10.3%0.029%Search for SEC Filing on Google Icon
4/21/2022Virginia Retirement Systems ET AL13,100$0.25M0.0%-22.0%0.019%Search for SEC Filing on Google Icon
4/20/2022Sigma Planning Corp14,872$0.28M0.0%+30.6%0.022%Search for SEC Filing on Google Icon
4/20/2022Congress Asset Management Co. MA78,443$1.49M0.0%+10.8%0.114%Search for SEC Filing on Google Icon
4/19/2022Green Alpha Advisors LLC48,413$0.92M0.6%+33.7%0.071%Search for SEC Filing on Google Icon
4/19/2022ARK Investment Management LLC797,241$15.16M0.1%-81.1%1.164%Search for SEC Filing on Google Icon
4/14/2022McGuire Investment Group LLC18,748$0.36M0.1%+5.4%0.027%Search for SEC Filing on Google Icon
4/12/2022Crestwood Advisors Group LLC18,160$0.35M0.0%-6.0%0.027%Search for SEC Filing on Google Icon
2/28/2022Vienna Asset Management LLC2,753$73K0.1%N/A0.004%Search for SEC Filing on Google Icon
2/23/2022Barclays PLC94,494$2.51M0.0%+4.1%0.138%Search for SEC Filing on Google Icon
2/15/2022Seven Eight Capital LP10,472$0.28M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/15/2022Stansberry Asset Management LLC28,085$0.75M0.1%+150.1%0.041%Search for SEC Filing on Google Icon
2/15/2022Marshall Wace LLP386,627$10.26M0.0%N/A0.565%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC988,290$26.24M0.0%-2,783.7%1.445%Search for SEC Filing on Google Icon
2/15/2022Capital Impact Advisors LLC21,537$0.57M0.4%-9.4%0.031%Search for SEC Filing on Google Icon
2/15/2022Capital World Investors1,100,000$29.21M0.0%-15.4%1.608%Search for SEC Filing on Google Icon
2/15/20221492 Capital Management LLC45,116$1.20M0.6%N/A0.066%Search for SEC Filing on Google Icon
2/14/2022Lombard Odier Asset Management Switzerland SA313,322$8.32M0.5%+50.3%0.458%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC106,337$2.82M0.2%+58.2%0.155%Search for SEC Filing on Google Icon
2/14/2022Point72 Hong Kong Ltd2,935$78K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/14/2022Guggenheim Capital LLC42,769$1.14M0.0%+46.8%0.063%Search for SEC Filing on Google Icon
2/14/2022State Street Corp3,274,607$86.94M0.0%+51.7%4.788%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.985,154$26.16M0.0%-28.6%1.440%Search for SEC Filing on Google Icon
2/14/2022Nuveen Asset Management LLC558,443$16.01M0.0%-10.6%0.816%Search for SEC Filing on Google Icon
2/14/2022Blair William & Co. IL14,778$0.39M0.0%+13.9%0.022%Search for SEC Filing on Google Icon
2/14/2022ClariVest Asset Management LLC18,497$0.49M0.0%+70.0%0.027%Search for SEC Filing on Google Icon
2/14/2022Barclays PLC94,494$2.51M0.0%+4.1%0.138%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP11,201$0.30M0.0%+63.2%0.016%Search for SEC Filing on Google Icon
2/14/2022Rockefeller Capital Management L.P.1,633$43K0.0%-79.3%0.002%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Editas Medicine logo
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing gene-edited Natural Killer cell medicines to treat solid tumor cancers; alpha-beta T cells for multiple cancers; and gamma delta T cell therapies to treat cancer, as well as has an early discovery program to develop a therapy to treat a neurological disease. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited to discover, develop, and commercialize new gene editing medicines for a range of ocular disorders; and research collaboration with Asklepios BioPharmaceutical, Inc. to develop a therapy to treat a neurological disease, as well as research collaboration with AskBio. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Read More on Editas Medicine

Today's Range

Now: $12.37
Low: $11.63
High: $12.44

50 Day Range

MA: $12.05
Low: $9.99
High: $15.81

52 Week Range

Now: $12.37
Low: $9.59
High: $73.03

Volume

6,135 shs

Average Volume

1,810,446 shs

Market Capitalization

$849.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.07

Who are the company insiders with the largest holdings of Editas Medicine?

Editas Medicine's top insider investors include:
  1. Michelle Robertson (CFO)
  2. Mark S Shearman (EVP)
  3. Bruce Eaton (EVP)
  4. Charles Albright (EVP)
  5. Cynthia Collins (CEO)
  6. James C Mullen (CEO)
  7. Lisa Anne Michaels (EVP)
Learn More about top insider investors at Editas Medicine.
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!